Vaccine triggers fierce response to fight brain tumor
UF-developed mRNA vaccine quickly reprogrammed the immune system to attack glioblastoma.
Posts tagged as
Brain Tumor Immunotherapy
New algorithm predicts targets for brain tumor immunotherapy, UF study shows
Study details novel method to create personalized mRNA-based vaccines to target brain tumors.
Innovative immunotherapy for malignant brain tumors
Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.
UF brain cancer researcher awarded St. Baldrick’s Foundation grant
Dr. Lan Hoang-Minh seeks to improve adoptive T cell therapy for pediatric brain tumor treatment.
Fighting pediatric cancer focus of V Foundation-UF Health collaboration
Dr. Duane Mitchell and his team received funding to bolster clinical research programs advancing novel immunotherapy treatments.
Renowned brain tumor researcher named CTSI director
Dr. Duane Mitchell named CTSI director, will lead UF’s efforts to move research discoveries to patients.
Meeting of the minds
In the latest edition of Florida Physician, read how UF brings together the world’s leading experts to help rewrite the story of brain cancer.
UF brain cancer researcher earns R01 grant
Dr. Catherine Flores will expand her research into a new use of stem cells to enhance the clinical effectiveness of adoptive T cell therapy against brain tumors.
Media coverage of The Harris Rosen Foundation gift announcement
See media highlights stemming from Feb. 22's announcement of The Harris Rosen Foundation's gift to advance brain tumor immunotherapy research at the MBI and launch the ReMission Alliance Against Brain Tumors.
